References
- Gottschalk I, Berg C, Harbeck N, et al. Fetal renal insufficiency following trastuzumab treatment for breast cancer in pregnancy: case report und review of the current literature. Breast Care. 2011;6(6):475–478.
- Zagouri F, Sergentanis TN, Chrysikos D, et al. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137(2):349–357.
- Azim HA, Jr., Peccatori FA, Liptrott SJ, et al. Breast cancer and pregnancy: how safe is trastuzumab? Nat Rev Clin Oncol. 2009;6(6):367–370.
- Fanale MA, Uyei AR, Theriault RL, et al. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer. 2005;6(4):354–356
- Watson WJ. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol. 2005;105(3):642–643.
- Witzel ID, Müller V, Harps E, et al. Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol. 2008;19(1):191–192.
- Gottschalk I, Berg C, Harbeck N, et al. Fetal renal insufficiency following trastuzumab treatment for breast cancer in pregnancy: case report und review of the current literature. Breast Care (Basel). 2011;6(6):475–478.
- Shlensky V, Hallmeyer S, Juarez L, et al. Management of breast cancer during pregnancy: are we compliant with current guidelines? AJP Rep. 2017;7(1):e39–e43.
- Andrade JM, Brito LG, Moises EC, et al. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up. Anti Cancer Drugs. 2016;27(4):369–372.
- Pianca N, Shafiei M, George M. Trastuzumab exposure in early pregnancy for a young Lady With locally invasive breast cancer. World J Oncol. 2015;6(3):381–382.
- El-Safadi S, Wuesten O, Muenstedt K. Primary diagnosis of metastatic breast cancer in the third trimester of pregnancy: a case report and review of the literature. J Obstet Gynaecol Res. 2012;38(3):589–592.
- Mandrawa CL, Stewart J, Fabinyi GC, et al. A case study of trastuzumab treatment for metastatic breast cancer in pregnancy: fetal risks and management of cerebral metastases. Aust N Z J Obstet Gynaecol. 2011;51(4):372–376.
- Roberts NJ, Auld BJ. Trastuzamab (Herceptin)-related cardiotoxicity in pregnancy. J R Soc Med. 2010;103(4):157–159.
- Goodyer MJ, Ismail JR, O’Reilly SP, et al. Safety of trastuzumab (Herceptin) during pregnancy: two case reports. Cases J. 2009;2:9329.
- Beale JM, Tuohy J, McDowell SJ. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios. Am J Obstet Gynecol. 2009;201(1):e13–e14.
- Warraich Q, Smith N. Herceptin therapy in pregnancy: continuation of pregnancy in the presence of anhydramnios. J Obstet Gynaecol J Inst Obstet Gynaecol. 2009;29(2):147–148.
- Pant S, Landon MB, Blumenfeld M, et al. Treatment of breast cancer with trastuzumab during pregnancy. J Clin Oncol. 2008;26(9):1567–1569.
- Shrim A, Garcia-Bournissen F, Maxwell C, et al. Favorable pregnancy outcome following trastuzumab (Herceptin) use during pregnancy – case report and updated literature review. Reprod Toxicol. 2007;23(4):611–613.
- Sekar R, Stone PR. Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol. 2007;110(2 Pt 2):507–510.
- Bader AA, Schlembach D, Tamussino KF, et al. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol. 2007;8(1):79–81.
- Waterston AM, Graham J. Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol. 2006;24(2):321–322.
- Weber-Schoendorfer C, Schaefer C. Trastuzumb exposure during pregnancy. Reprod Toxicol (Elmsford, NY). 2008;25(3):390–391.